| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.00096 | 1 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.0008 | 1 |